All Pfizer published press releases by date and/or category of news
08.08.2022 Financial Investments Pfizer to Acquire Global Blood Therapeutics for $5.4 Billion to Enhance Presence in Rare Hematology 06.28.2022 Financial Investments Roivant and Pfizer Unveil Priovant Therapeutics and Ongoing Registrational Studies for Oral Brepocitinib in Dermatomyositis and Lupus 06.23.2022 Financial Investments Vaccines Valneva and Pfizer Announce Closing of Equity Investment
Rocky Mount Latest News
Updates and news about our Rocky Mount manufacturing site
- Newest Update:
- Latest Press Release: Pfizer Announces Post-Tornado Relief Plans for Rocky Mount Community and Manufacturing Facility
- Site Fact Sheet: Rocky Mount Fact Sheet (PDF)
- Downloadable Photos & Video: Media Asset Library
Media Asset Library
A collection of assets for use by media.
The latest news from Pfizer and its strategic partners
07.31.2023 Corporate Partnerships Arvinas and Pfizer Awarded Innovation Passport Designation by the U.K. Innovative Licensing and Access Pathway Steering Group for Vepdegestrant, an Investigational PROTAC® ER degrader being developed in ER+/HER2- Breast Cancer 07.18.2023 Corporate Partnerships Flagship Pioneering and Pfizer Partner to Accelerate Development of Innovative Medicines Targeting Unmet Needs
Pfizer Media Relations
We encourage everyone to view our press releases, press statements, and press kits to stay up to date on Pfizer news.
However, to ensure that customers, investors, and others receive the appropriate attention, Pfizer media contacts may only respond to calls and emails from professional journalists.
United States, Canada and Latin America
What we need
To best help us help you, please be prepared to provide your name and email address, a summary of the article you're working on and your deadline.
Stay up to date on the latest news and alerts through the Pfizer Wire
Sign up to receive real-time updates on Pfizer’s news from the Pfizer Media Relations team delivered directly to your inbox.